Dhaka, Bangladesh (BBN)– LankaBangla Finance dominated the country’s premier bourse transaction chart last week that ended on Thursday.
Brokers said investors took position on its shares heavily riding on upcoming earnings and dividend announcement speculation.
According to the statistics available with the DSE, about 27.56 million shares of LankaBangla were traded, generating a turnover of BDT 1.34 billion last week. It was 3.64 percent of the week’s total turnover value.
The non-bank financial institution’s share price closed at BDT 51.90 each on Thursday, the last session of the week, soaring 19.86 percent over the previous week. It was also the week’s highest gainer.
The company’s third quarter (Q3) consolidated earnings per share (EPS) stood at BDT 0.19 for the July-September period of 2016 as against BDT 0.33 for the same period a year ago.
In nine months for the July-September period of 2016, consolidated EPS was BDT 1.21 as against BDT 0.43 for the January-September 2015.
LankaBangla Finance, which was listed on the Dhaka bourse in 2006, disbursed 15 percent cash and 15 per cent stocks dividend for the year ended on December 31, 2015.
The company’s paid-up capital is BDT 2.77 billion and authorized capital is BDT 3.0 billion, while the total number of securities is 276.74 million. The total market capitalisation stood at BDT 13.56 billion as on Thursday.
The sponsor-directors own 34.83 per cent stake in LankaBangla, while institutional investors own 31.74 per cent, foreign investors 2.39 per cent and the general public 31.04 per cent as on December 29, 2016, the DSE data shows.
LankaBangla was, closely followed ACI Formulations with 5.39 million shares of BDT 1.05 billion changing hands, followed by Beximco BDT 996 million, Pacific Denims BDT 976 million, Saif Powertec BDT 969 million and Ratanpur Steel Re-rolling Mills BDT 942 million.
Appollo Ispast Complex was also included in the week’s top ten turnover chart with 40.51 million shares of BDT 918 million changing hands, followed by Islami Bank BDT 887 million, Central Pharma BDT 758 million and IDLC Finance BDT 732 million.

BBN/SSR/SR